In Vitro Activity of Antifungals in Combination With Meropenem or Daptomycin Against Dual Candida albicans –Bacterial Biofilms
APMIS · 2025
DOI: 10.1111/apm.70047 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Agim Osmani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey. Hauptthemen laut MEDLINE: Biofilms, Daptomycin, Meropenem, Antifungal Agents. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: scientific and technological research council of turkey (tubitak), Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (Originalsprache)
The objective was to investigate the effectiveness of anidulafungin (ANI), voriconazole (VOR), and amphotericin (AMB) combined with meropenem against dual biofilms of Candida albicans and Pseudomonas aeruginosa , as well as with daptomycin against dual biofilms of C. albicans – Staphylococcus epidermidis . MIC values of antifungals were determined by CLSI M27‐A3 method. The effectiveness of antifungals in combination with antibiotics against biofilms was tested by Checkerboard analysis. Biofilm quantifications were tested by the XTT method. The biofilm images were captured using SEM. The quantity of C. albicans – S. epidermidis and C. albicans – P. aeruginosa was lower (83.2% and 56.3%, respectively) than that of single Candida biofilm. The SMIC50 values for single C. albicans biofilms were 32‐fold higher for AMB and VOR, and 128‐fold higher for ANI when compared to dual Candida biofilms. Daptomycin combined with ANI or VOR showed antagonistic effects against C. albicans – S. epidermidis biofilms, while meropenem in combination with all antifungals was found to be additive against C. albicans – P. aeruginosa biofilms. Antifungals and their combinations resulted in a decrease in blastospore and bacterial density, as observed through SEM. In C. albicans – P. aeruginosa biofilms, using meropenem alongside antifungals would be beneficial due to its additive effect. Daptomycin combined with ANI or VOR may not be effective in C. albicans – S. epidermidis coinfections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey.
- Department of Molecular Gastroenterology and Hepatology, Institute of Gastroenterology and Hepatology, Kocaeli University, Kocaeli, Turkey.
- Department of Medical Services and Techniques, Vocational School of Health Services, Kocaeli University, Kocaeli, Turkey.
- Department of Histology and Embryology, Marmara University Faculty of Medicine, Istanbul, Turkey.
ORCID-Profile: Sema Askın Keceli
Förderung
- scientific and technological research council of turkey (tubitak)
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Zitieren
APA
Osmani, A., Keceli, S. A., Er, D. K., Uzuner, H., Ercan, F., & Koroğlu, A. K. (2025). In Vitro Activity of Antifungals in Combination With Meropenem or Daptomycin Against Dual Candida albicans –Bacterial Biofilms. APMIS. https://doi.org/10.1111/apm.70047
Vancouver
Osmani A, Keceli SA, Er DK, Uzuner H, Ercan F, Koroğlu AK. In Vitro Activity of Antifungals in Combination With Meropenem or Daptomycin Against Dual Candida albicans –Bacterial Biofilms. APMIS. 2025. doi:10.1111/apm.70047
BibTeX
@article{Osmani2025,
author = {Osmani, Agim and Keceli, Sema Askın and Er, Doganhan Kadir and Uzuner, Huseyin and Ercan, Feriha and Koroğlu, Ayca Karagoz},
title = {In Vitro Activity of Antifungals in Combination With Meropenem or Daptomycin Against Dual Candida albicans –Bacterial Biofilms},
journal = {APMIS},
year = {2025},
doi = {10.1111/apm.70047}
}
EUVIMED